Article thumbnail

Expression of the Stress Response Oncoprotein LEDGF/p75 in Human Cancer: A Study of 21 Tumor Types

By Anamika Basu, Heather Rojas, Hiya Banerjee, Irena B. Cabrera, Kayla Y. Perez, Marino De León and Carlos A. Casiano

Abstract

Oxidative stress-modulated signaling pathways have been implicated in carcinogenesis and therapy resistance. The lens epithelium derived growth factor p75 (LEDGF/p75) is a transcription co-activator that promotes resistance to stress-induced cell death. This protein has been implicated in inflammatory and autoimmune conditions, HIV-AIDS, and cancer. Although LEDGF/p75 is emerging as a stress survival oncoprotein, there is scarce information on its expression in human tumors. The present study was performed to evaluate its expression in a comprehensive panel of human cancers. Transcript expression was examined in the Oncomine cancer gene microarray database and in a TissueScan Cancer Survey Panel quantitative polymerase chain reaction (Q-PCR) array. Protein expression was assessed by immunohistochemistry (IHC) in cancer tissue microarrays (TMAs) containing 1735 tissues representing single or replicate cores from 1220 individual cases (985 tumor and 235 normal tissues). A total of 21 major cancer types were analyzed. Analysis of LEDGF/p75 transcript expression in Oncomine datasets revealed significant upregulation (tumor vs. normal) in 15 out of 17 tumor types. The TissueScan Cancer Q-PCR array revealed significantly elevated LEDGF/p75 transcript expression in prostate, colon, thyroid, and breast cancers. IHC analysis of TMAs revealed significant increased levels of LEDGF/p75 protein in prostate, colon, thyroid, liver and uterine tumors, relative to corresponding normal tissues. Elevated transcript or protein expression of LEDGF/p75 was observed in several tumor types. These results further establish LEDGF/p75 as a cancer-related protein, and provide a rationale for ongoing studies aimed at understanding the clinical significance of its expression in specific human cancers

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3261859
Provided by: PubMed Central

Suggested articles

Citations

  1. (2009). Aberrant DNA methylation profile of hepatocellular carcinoma and surgically resected margin.
  2. (2000). Activation of LEDGF gene by thermal-and oxidative-stresses.
  3. (2008). Alternative splicing and caspase-mediated cleavage generate antagonistic variants of the stress oncoprotein LEDGF/p75.
  4. (2005). Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis.
  5. (2000). Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions.
  6. (2004). Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying to tell us?
  7. Casiano CA (2009) Autoantibodies to LEDGFp75/DFS70: natural autoantibodies or sensors of an augmented state of cellular oxidative stress? In:
  8. (2002). Caspase cleavage of the nuclear autoantigen LEDGF/p75 abrogates its pro-survival function: implications for autoimmunity in atopic disorders.
  9. (2006). Cellular co-factors of HIV-1 integration.
  10. (2011). Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.
  11. (2009). Differential gene expression in tumor adjacent histologically normal prostatic tissue indicates field cancerization.
  12. (2002). Discordant protein and mRNA expression in lung adenocarcinomas.
  13. (2006). Disruption of Ledgf/Psip1 results in perinatal mortality and homeotic skeletal transformations.
  14. (2001). Dobrovic A
  15. (2009). Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75.
  16. (2009). Evidence for field cancerization of the prostate.
  17. (2002). Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of nonExpression of
  18. (2009). Gonadotropin-regulated lymphangiogenesis in ovarian cancer is mediated by LEDGF-induced expression of VEGF-C.
  19. (2000). Heparin’s roles in stabilizing, potentiating, and transporting LEDGF into the nucleus.
  20. (2010). Hsp60 is actively secreted by human tumor cells.
  21. (2008). Integrase, LEDGF/p75 and HIV replication.
  22. (2005). Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.
  23. (1998). Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation.
  24. (2008). LEDGF binding to stress response element increases alphaB-crystallin expression in astrocytes with oxidative stress.
  25. (2001). LEDGF binds to heat shock and stress-related element to activate the expression of stressrelated genes.
  26. (2007). LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro.
  27. (2007). Lens epithelium-derived growth factor is an Hsp70-2 regulated guardian of lysosomal stability in human cancer.
  28. (2000). Lens epithelium-derived growth factor: effects on growth and survival of lens epithelial cells, keratinocytes, and fibroblasts.
  29. (2000). Lens epitheliumderived growth factor (LEDGF/p75) and p52 are derived from a single gene by alternative splicing.
  30. (2002). Lens epitheliumderived growth factor: increased survival and decreased DNA breakage of human RPE cells induced by oxidative stress.
  31. (2010). Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumors.
  32. (2008). Menin critically links MLL proteins with LEDGF on cancer-associated target genes.
  33. (2010). Metastasis: cancer cell’s escape from oxidative stress.
  34. (2007). Modulation of LMP1 protein expression by EBV-encoded microRNAs.
  35. (2005). NUP98-LEDGF fusion and t(9;11) in transformed chronic myeloid leukemia.
  36. (2010). Overexpression of LEDGF/DFS70 induces IL-6 via p38 activation in HaCaT cells, similar to that seen in the psoriatic condition.
  37. (2009). Overexpression of peroxiredoxin 1 and thioredoxin1 in human breast carcinoma.
  38. (2009). Oxidative stress in environmental-induced carcinogenesis.
  39. (2010). Oxidative stress, inflammation, and cancer: how are they linked? Free Radic
  40. (2011). Pathway specific gene expression profiling reveals oxidative stress genes potentially regulated by transcription co-activator LEDGF/p75 in prostate cancer cancer cells. Prostate;[July 27, Epub ahead of print].
  41. (2008). Pdcd4 protein and mRNA level alterations do not correlate in human lung tumors.
  42. (2010). Proteomic analysis of field cancerization in pharynx and oesophagus: a prospective pilot study.
  43. (2010). Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation.
  44. (2011). Survivin is released from cancer cells via exosomes.
  45. (2000). t(9;11)(p22;p15) in acute myeloid leukemia results in a fusion between NUP98 and the gene encoding transcriptional coactivators p52 and p75-lens epitheliumderived growth factor (LEDGF).
  46. (2005). t(9;11)(p22;p15) with NUP98-LEDGF fusion gene in pediatric acute myeloid leukemia.
  47. (2006). Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumors.
  48. (2008). The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication.
  49. (2007). Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol Cancer Ther
  50. (2001). Transcriptional regulation of the antioxidant protein 2 gene, a thiol-specific antioxidant, by lens epithelium-derived growth factor to protect cells from oxidative stress.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.